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cells from nasopharyngeal carcinoma
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Paulisally Hau Yi Lo1, Marian L Waterman2 and Maria Li Lung1*Abstract
Background: A few reports suggested that low levels of Wnt signaling might drive cell reprogramming, but these
studies could not establish a clear relationship between Wnt signaling and self-renewal networks. There are
ongoing debates as to whether and how the Wnt/β-catenin signaling is involved in the control of pluripotency
gene networks. Additionally, whether physiological β-catenin signaling generates stem-like cells through
interactions with other pathways is as yet unclear. The nasopharyngeal carcinoma HONE1 cells have low expression
of β-catenin and wild-type expression of p53, which provided a possibility to study regulatory mechanism of
stemness networks induced by physiological levels of Wnt signaling in these cells.
Results: Introduction of increased β-catenin signaling, haploid expression of β-catenin under control by its natural
regulators in transferred chromosome 3, resulted in activation of Wnt/β-catenin networks and dedifferentiation in
HONE1 hybrid cell lines, but not in esophageal carcinoma SLMT1 hybrid cells that had high levels of endogenous
β-catenin expression. HONE1 hybrid cells displayed stem cell-like properties, including enhancement of CD24+ and
CD44+ populations and generation of spheres that were not observed in parental HONE1 cells. Signaling cascades
were detected in HONE1 hybrid cells, including activation of p53- and RB1-mediated tumor suppressor pathways,
up-regulation of Nanog-, Oct4-, Sox2-, and Klf4-mediated pluripotency networks, and altered E-cadherin expression
in both in vitro and in vivo assays. qPCR array analyses further revealed interactions of physiological Wnt/β-catenin
signaling with other pathways such as epithelial-mesenchymal transition, TGF-β, Activin, BMPR, FGFR2, and LIFR-
and IL6ST-mediated cell self-renewal networks. Using β-catenin shRNA inhibitory assays, a dominant role for β-
catenin in these cellular network activities was observed. The expression of cell surface markers such as CD9, CD24,
CD44, CD90, and CD133 in generated spheres was progressively up-regulated compared to HONE1 hybrid cells.
Thirty-four up-regulated components of the Wnt pathway were identified in these spheres.
Conclusions: Wnt/β-catenin signaling regulates self-renewal networks and plays a central role in the control of
pluripotency genes, tumor suppressive pathways and expression of cancer stem cell markers. This current study
provides a novel platform to investigate the interaction of physiological Wnt/β-catenin signaling with stemness
transition networks.
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Multiple groups have shown that different dosage levels
of Wnt signaling contribute to distinct cellular activities
such as reprogramming, differentiation, tumorigenesis,
and epithelial-mesenchymal transition (EMT) events
[1-4]. Inappropriate activation of components of this sig-
naling pathway has been observed in some human can-
cers and differentiating stem cells, in which high levels
of Wnt signaling were often detected [1,4-8]. Therefore,
Wnt signaling has multiple functions in cell fate deter-
mination and is involved in generation of cancer stem
cells (CSCs). However, there are unresolved issues for
the role of Wnt/β-catenin signaling in the regulation of
either self-renewal or differentiation networks in human
cells [4,5,7,9,10].
Nasopharyngeal carcinoma (NPC) is a unique cancer,
which is particularly prevalent among the southern
Chinese, but rare in most other areas around the world
[11,12]. Unlike other common tumors, how Wnt signal-
ing influences NPC and crosstalks to other networks to
affect cell differentiation and growth, including regula-
tion of CSC markers and EMT events, is unknown. NPC
was reported to have an infrequent mutation of tumor
suppressor gene (TSG) p53 and wild-type RB1 expres-
sion [11-14]; they both play critical roles in the control
of the reprogramming process, self-renewal, and other
cell fate determinations [15-17]. Wnt signaling interacts
with p53 signaling [18-20] and usually acts in a dosage-
dependent and tissue-specific manner for many cellular
processes [1,21-26]. Therefore, it is possible to reveal
novel findings by exploring the regulatory mechanism of
Wnt signaling in wild-type p53 expressing tumors such
as with NPC HONE1 cells.
We previously established several microcell hybrid cell
(MCH) lines derived from HONE1 cells containing
a transferred copy of chromosome 3 [11]. Because a
physiological or basic level of Wnt signaling acts as a de-
terminant factor in the regulation of stem cells and self-
renewing tissues [3,25,27,28] and HONE1 cells have very
low endogenous expression of β-catenin, a major medi-
ator of Wnt signaling, we hypothesized that introduction
of another copy of the β-catenin gene (CTNNB1) via sin-
gle copy transfer of chromosome 3 may generate physio-
logical levels of β-catenin signaling due to the haploid
level of expression of the transferred genes under con-
trol by their natural regulators. This approach differs
from gene transfection studies that often cause artificial
overexpression of the transferred genes [25]. In many
cancer cells, stem cell-related genes are often expressed.
Exogenous β-catenin signaling may regulate these en-
dogenous signaling networks, thus changing the direc-
tion of cellular differentiation. Additionally, p53, RB1, or
other possible TSGs, often serve as negative barriers for
the reprogramming and self-renewal processes [15,16].Delicate control of relevant signaling activities may drive
cells into a more de-differentiated status, revealing
signaling regulatory mechanisms during the stemness
transition process, a series of regulatory relationships
that are not fully understood in human cells.
It is important to determine what critical role β-catenin
plays in the transferred chromosome by examining the
relevant network activities in recipient cells. It is well-
accepted now that Wnt/β-catenin signaling interacts with
many other signaling networks such as pluripotency,
cadherins, EMT, transforming growth factor-β (TGF-β),
fibroblast growth factor (FGF), and TSG signaling
[1,8,15,16,26,29,30]. If Wnt/β-catenin signaling is activated,
these relevant network activities are expected to be detected
in treated cells. For example, altered expression of E-
cadherin and EMT markers should be found in these cells.
Therefore, whether Wnt signaling, initiated at a basic and
physiological level, is able to induce other signaling path-
ways during the progress of stemness transition, or to gen-
erate stem-like cells from human cancer cells, such as
NPC, is the focus of this study.Results
Monochromosome 3 transfer confers physiological
increases of β-catenin that up-regulates expression of
core stem cell genes
We previously established several HONE1 hybrid cell lines
that were confirmed to contain an exogenous copy of the
intact chromosome 3, following fusion of parental HONE1
and mouse MCH903.1 donor cells [11]. Figure 1A shows
that both HONE1 and MCH903.1 cells have similar and
low expression levels of the human β-catenin, consistent
with their having physiological levels of β-catenin signaling.
Human embryonic stem cells, H7 [31], were used as a posi-
tive control for mRNA expression of stem cell genes and β-
catenin. The up-regulation of β-catenin expression was
clearly detected in all three HONE1 hybrid cell lines, as
compared to HONE1, and is similar to that detected in H7
cells. Both c-Myc and Axin2 are major targets of the Wnt
pathway and Tcf1 and Tcf3 are terminal components of the
β-catenin signaling pathway in the nucleus. The expression
of Axin2 was detected in HONE1 hybrid cells, but not in
H7 cells and parental HONE1 cells. The expression of Tcf1,
Tcf3, and c-Myc were obviously up-regulated in these
HONE1 hybrid cells, compared with parental HONE1 cells
(Figure 1A).
Significant expression of pluripotency genes, Nanog,
Oct4, and Klf4, at the RNA level was detected in HONE1
hybrid cells compared to parental HONE1 cells. Both
HONE1 and mouse MCH903.1 cells show endogenous
expression of human Sox2 gene, but in HONE1 hybrid
cells this gene was up-regulated and had similar expres-
sion levels as seen in H7 cells (Figure 1A).
Figure 1 Exogenous β-catenin signaling induces Wnt pathway and stem cell-related network activities in HONE1 hybrid cells. A. RT-PCR
analyses for HONE1, MCH903.1, HONE1 hybrid cells (MCH4.4/4.5/4.6) and human embryonic stem cells H7. B. Immunofluorescence staining shows
that β-catenin proteins clearly accumulate in the cellular membrane in most of hybrid cells (MCH4.6). C. Western blot analysis reveals that protein
expression of β-catenin, Axin2, Nanog, Oct4 and E-cadherin is up-regulated in HONE1 hybrid cells, but N-cadherin is down-regulated. D.
Luciferase assay shows increased Wnt activities in HONE1 hybrid cells. STOP/SFOP values are increased by 70-fold in MCH4.6 cells compared to
parental HONE1 cells. E. Immunohistochemical staining shows consistent expression of Wnt target genes in mouse models. In tumor samples,
protein expressions of β-catenin, E-cadherin, and Cyclin D1 are strongly up-regulated in tissues derived from two HONE1 hybrid cell lines
(MCH4.5-1TS and MCH4.6-1TS), 40x magnification. Bars, 20 μm. F. RT-PCR analysis shows that loss of transferred chromosome fragment containing
an exogenous β-catenin copy (MCH4.5-2TS) is associated with concomitant loss of up-regulated expression of endogenous genes.
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around membranes was clearly detected in the majority
of hybrid cells compared to parental HONE1 cells by
immunofluorescence staining (Figure 1B). As expected,
up-regulated protein levels of β-catenin, Axin2, Nanog,
and Oct4 were detected by Western blot analyses
(Figure 1C). Compared with parental HONE1 cells,E-cadherin was up-regulated and N-cadherin was down-
regulated in the HONE1 hybrid cells.
Enhanced Wnt/TCF/LEF network activity is maintained
in vivo
A luciferase assay was performed using a Wnt/TCF re-
porter plasmid that carries a large array of Wnt response
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signals. As shown in Figure 1D, transient transfection of
the superTOPGAL reporter detected an increased level
of Wnt signaling by approximately 70-fold in HONE1
hybrid cells.
Immunohistochemical staining of the xenograft tu-
mors demonstrated that β-catenin, E-cadherin, and
Cyclin D1, the target of Wnt signaling, were strongly
up-regulated in tumor segregants (TSs) derived from
HONE1 hybrids, as compared with control tumors from
the parental HONE1 and MCH4.5-2TS cells. Both β-
catenin and E-cadherin proteins clearly accumulated at
the membrane (Figure 1E), consistent with the pattern
shown in Figure 1B cultured cells.
It has long been known that some regions of trans-
ferred chromosomes in TSs are selectively lost during
tumor growth and the expression of relevant exogenous
genes reverts back to levels similar to parental HONE1
cells [11,12,32-34]. Xenograft tumors derived from
HONE1 hybrid cells were, therefore, analyzed for β-
catenin expression (Figure 1F). For three of the HONE1
hybrid tumor sets (MCH4.5-1TS/4.6-1TS/4.6-2TS), in-
creased β-catenin levels were evident as well as in-
creased levels of endogenous stem cell genes Nanog and
Oct4, compared to corresponding hybrid cells. A fourth
hybrid cell line tumor, MCH4.5-2TS (see Figure 1E), did
not show up-regulated expression of exogenous β-
catenin and also did not have increased expression of
Nanog and Oct4.
Physiological expression of exogenous β-catenin is
essential for the up-regulation of the endogenous core
stem cell network
To further confirm whether expression of exogenous β-
catenin is a major determinant in the regulation of the
core stem cell network in HONE1 hybrid cells, we
performed inhibitory assays using short hairpin RNAs
(shRNAs) that silence β-catenin expression in infected
cells. A scrambled shRNA was used as a negative control
in all experiments. HONE1 hybrid cells with infected
scramble shRNA have up-regulated expression of β-
catenin compared to parental HONE1 cell (Top panel,
Figure 2A). HONE1 hybrid cells with infected β-catenin
shRNA have reduced expression of β-catenin and repre-
sentative results from various passages of cell popula-
tions after infection of shRNA plasmids are shown in
the bottom panel, Figure 2A. β-catenin expression was
reduced by approximately 54%, 97%, 70%, and 79% in
MCH4.5 and MCH4.6 cell lines at different passage
levels after infection. In these β-catenin shRNA-infected
cells, expression of Nanog, Oct4, Sox2, and Klf4 was
inhibited as observed by qPCR analyses (Figure 2B).
Figure 2C shows that expression of β-catenin, E-
cadherin, Sox2, Zeb1, and Fn1 proteins were clearlydecreased in both β-catenin shRNA-treated cell lines.
The inhibited expression of Oct4 was seen in MCH4.6
(4), and inhibition of Klf4 was detected in MCH4.5(5),
but no obvious expression change was detected for
N-cadherin and Nanog. These results suggest that β-
catenin signaling in HONE1 hybrid cells is involved in
both stemness and EMT networks.HONE1 hybrid cells are poorly differentiated and exhibit
stem cell-like properties
Parental HONE1 cells grow as monolayers that do
not form spheres under ordinary culture conditions,
evidenced by our long-term culture of these cells [11].
In contrast, after 45 to 90 days in standard culture, 158
spheres from independent experiments were observed in
the HONE1 hybrid cultures (Figure 3A). The size of all
spheres was larger than 20 μM in diameters, which was
not detected in parental HONE1 and HONE1 hybrid cell
lines with infected β-catenin shRNA. These results sug-
gest that sphere-forming cells had lost contact inhibition
and had undergone a dedifferentiation process.
Since CSC markers, CD24 and CD44, are commonly
expressed in many stem-like cells, we investigated ex-
pression changes of these two markers by FACS analysis.
CD24+, CD44+, and CD24+/CD44+ populations were
markedly increased from 23% to 53.2%, 35.7% to 77.9%,
and 42.7% to 77.2%, respectively, in HONE1 hybrid cells
compared to parental HONE1 cells (Figure 3B).Physiological Wnt levels trigger multiple signaling
activities during the regulation of stem cell gene
networks
The qPCR array results confirmed that pluripotency
genes, Sox2, Klf4, Oct4, and Nanog, are clearly up-
regulated in HONE1 hybrid cells, compared with
parental HONE1 cells. In addition, many other rele-
vant genes such as HOXA9, RB1, ZIC1, WRN, TDGF1,
LIN28B, and WT1 are considerably up-regulated in
these HONE1 hybrid cells (Figure 4A), supporting the
stem cell-like properties of these cells and activation of
known genes related to self-renewal networks.
The exogenous copy of β-catenin in HONE1 hybrid
cells induced signaling cascades involved in multiple
pathways such as Wnt, TGF-β superfamily containing
BMP and Activin receptors, pluripotency maintenance,
and FGF signaling (Figure 4B). For Wnt signaling,
enhanced expression of the non-canonical NFAT family
and Wnt receptors, FZD3, FZD5, and FZD6, was
detected in these cells. However, the Stem Cell Signal-
ing Array did not detect significant changes of signals
from Hedgehog and Notch pathways (Additional file 1:
Table S1).
Figure 2 shRNA knockdown of β-catenin is associated with the regulation of Wnt pathway, EMT, and pluripotency networks. A. The top
panel shows that HONE1 hybrid cells have an up-regulated expression of β-catenin by qPCR analyses, compared to the parental HONE1 cells.
MCHs 4.5 and 4.6 are infected by scramble (empty bars) and β-catenin shRNAs (black bars). The number in parenthesis refers to the growth
passages of cells after infection. Fold-changes reflect inhibitory expression of β-catenin in these cells compared to corresponding scramble
negative controls. β-catenin expression is reduced in all four cell lines, as shown in the bottom panel. B. qPCR analyses show inhibited expression
of Nanog, Oct4, Sox2, and Klf4 in β-catenin shRNA infected cells. C. Western blot assay confirms that β-catenin shRNAs inhibit expression of β-
catenin, E-cadherin, core stem cell factors (Oct4, Klf4, and Sox2), and EMT factors (Zeb1 and Fn1) in the treated HONE1 hybrid cells.
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signaling activities as induced by chromosome 3 transfer
in HONE1 cells
The GSK-3-specific inhibitor, Bromoindirubin-3’-oxime
(BIO), activates Wnt signaling in stem cells and somatic
cells [5,10,27,35] and this small molecule was, therefore,
used to treat parental HONE1 cells to determine
whether it had an effect on core stem gene signaling
networks, similar to that seen in the HONE1 hybrid
cells. As shown in Figure 4C, 5 μM BIO treatment in-
duced the highest mRNA expression of β-catenin and
Axin2. BIO treatment in HONE1 cells up-regulated
mRNA expression of endogenous stem cell genes, Nanog
and Oct4, and EMT markers and regulators such as
Twist, Snail, Cyclin D1, Slug, Fn1, and E-cadherin. BIO
treatment also caused an up-regulation of N-cadherin in
HONE1 cells, suggesting that BIO treatment does not
fully mimic chromosome 3 transfer effects of inducing
physiological signaling in HONE1 cells. Bio-induced
β-catenin accumulation was mainly detected at the
membrane in treated cells (Figure 4D).To verify the critical role that physiological signaling
levels exert, BIO treatment was used to generate high, non-
physiological levels of β-catenin protein expression in cells.
Western blot analyses indicated that β-catenin, Axin2, and
E-cadherin were strongly up-regulated in BIO-treated
HONE1 cells. These results were also confirmed in
MCH4.5-2TS cells that lost a transferred copy of β-catenin
gene. Importantly, endogenous protein levels of Nanog and
Oct4 were not up-regulated in β-catenin over-expressing
HONE1 and MCH4.5-2TS cells (Figure 5A).
Chromosome 3 transfer does not affect cells with high
levels of endogenous β-catenin expression
To determine whether physiological β-catenin signal-
ing might regulate other human cells, esophageal car-
cinoma SLMT1 cells were examined [36]. The
endogenous levels of β-catenin expression in SLMT1
were higher than that of HONE1 cells, likely due to
an alternative transcript of β-catenin gene in exons 3/
5 in SLMT1 cell observed by RT-PCR and sequencing
analyses (data not shown). The expressions of both β-
Figure 3 HONE1 hybrid cells have properties of stem-like cells. A. Phase-contrast images of spheres that could be grown on the surface of
monolayer epithelial cells or bottom of flask (upper right and upper left). The bottom picture shows image of parental HONE1 cell growth. The
bar graph indicates that parental HONE1 cells and HONE1 hybrid cells with infected β-catenin shRNA (Hybrid/shB) do not form spheres in the
same culture conditions. B. FACS analyses (bar chart, Left) show that HONE1 hybrid cells (solid bars) contain more CD24+, CD44+, CD24+/CD44+
populations than those of HONE1 cells (empty bars). The figure (right) shows that hybrid cells have increased numbers of double positive
CD24+/CD44+ populations.
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SLMT1 hybrid cells, MCH3.11/3.22 [36], with an in-
troduced copy of chromosome 3, compared with their
parental SLMT1 cells (Figure 5B). Nanog and Oct4
protein expression was also unaltered in SLMT1-
derived hybrid cells (Figure 5C).
Tumor suppressor gene-mediated pathways are activated
in HONE1 hybrid cells
Because the tumor suppressor p53 circuit communi-
cates with the Wnt pathway and serves as a major
target in stem cells [15,18], the expression of p53 in
HONE1 hybrid cells was examined at both the RNA
and protein levels. Interestingly, p53 was up-regulated
and triggered by Wnt signaling in all these hybrid
cells by both RT-PCR (Figure 6A) and Western blot
analyses (Figure 6B). As described previously, other
tumor suppressors, such as RB1 and WT1 (Figure 4A),were also activated in these cells, consistent with
multiple tumor suppression pathways being activated
following introduction of physiological Wnt/β-catenin
signaling in HONE1 cells.
Since tumor suppression pathways were activated in
HONE1 hybrid cells due to the up-regulation of Wnt/
β-catenin signaling, it may affect growth ability of
cells. To test these possibilities, MTT and colony
formation assays in matrigel were performed with
both stable scramble and β-catenin shRNA-infected
HONE1 hybrid cells. The results indicated that tumor
cell growth was inhibited by the knockdown of Wnt/
β-catenin signaling in these cells (Figures 6B and 6C),
reflecting that activation of tumor suppressive signal-
ing has limited influence to control cell growth in
HONE1 hybrid cells. However, Wnt/β-catenin signal-
ing may stimulate cell growth during stemness transi-
tion process.
Figure 4 Physiological β-catenin signaling triggers multiple signaling pathways in HONE1 hybrid cells, and BIO-induced Wnt signaling
activities in HONE1 cells. A. Stem Cell Transcription Factors Array shows major transcription factors that are up-regulated in HONE1 hybrid cells.
B. The bottom panel demonstrates Stem Cell Signaling Array, showing that four signaling pathways are activated in HONE1 hybrid cells. C. RT-PCR
analyses show that both β-catenin and Axin2 are strongly expressed in BIO-treated cells. Except for N-cadherin that shows reduced levels in HONE1 hybrid
cells (also see Figure 1C, expression for all tested genes, β-catenin, Axin2, Nanog, Oct4, Twist, Snail, Cyclin D1, Slug, Fn1, and E-cadherin, is up-regulated in
both HONE1 hybrid (MCH4.5 and MCH4.6) and BIO-treated cells compared to mock-treated HONE1 cells. D. Immunofluorescence staining shows that
expressed proteins in BIO-treated HONE1 cells (5 μM) are mainly accumulated in the membrane (40x magnification) as compared to parental HONE1 cells.
This is also seen in HONE1 hybrid cells (Figures 1B and 1E).
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progressively up-regulated in sphere-forming cells
In the dedifferentiation progression of HONE1 to hybrid
to sphere cells, RNA expression of four core stem cell
genes, Nanog, Oct4, Sox2, and Klf4, was continuously
up-regulated in spheres compared to derived hybrid cells
(data not shown). Furthermore, some genes that encode
CSC surface markers (Table S2) were either expressed or
up-regulated by RT-PCR analysis in spheres, including
CD9, CD24, CD44, CD90, and CD133. Notably,
expression of genes that encode CD24 and CD133 was
detected in sphere-forming cells derived from pooled
large and small spheres from different experiments
(Figure 7A).
Consistent with findings obtained from Stem Cell
Signaling Array analysis (Figure 4A), many Wnt pathway
components were activated, including both those in ca-
nonical and non-canonical signaling. In spheres, LEF1was further increased 23-fold, compared to hybrid cells.
Other markedly up-regulated genes are DKK1 (23.5-
fold), FZD6 (29.7-fold), Wnt11 (34.9-fold), and FBXW2
(36.8-fold). Additionally, expression of some compo-
nents of Wnt signaling, such as GSK3A (−9.9-fold) and
the TLE repressor AES (−9.6-fold), were clearly inhibited
in these spheres, as seen in Figures 7B and 7C.
Discussion
Wnt signaling plays a substantial role in the control of
development of several types of tissues through a
dosage-dependent fashion. These regulated cells in-
clude crypt progenitor [28,37], hair follicle [38], and
hematopoietic stem cells [39]. All these observations
suggest that Wnt signaling is a dominant force in the
control of proliferation of progenitor or stem cells.
Our data further suggest that basic, moderate, physio-
logical levels of Wnt signaling are sufficient for these
Figure 5 The high levels of β-catenin signaling do not up-regulate Nanog and Oct4 expression in both HONE1 and SLMT1 cells. A.
Western blotting shows that both concentrations of 5 μM and 10 μM BIO treatment induce strong over-expression of β-catenin in treated cells,
but 10 μM BIO treatment causes strong cytotoxic effects in cells and possible reduced expression of Axin2 in HONE1 cells. Compared to mock-
treated HONE1 and MCH4.5-2TS cells, no obvious up-regulation of both Nanog and Oct4 expression is detected in β-catenin over-expressing
cells, but E-cadherin is clearly up-regulated in both BIO-treated cell lines. B. SLMT1 cells have high levels of expression of β-catenin and do not
respond to exogenous β-catenin signaling. RT-PCR analysis shows that HONE1 hybrid cells have an up-regulated expression of β-catenin and c-
Myc compared to their parental HONE1 cells, but no up-regulated change of β-catenin (exons 3/5) and c-Myc is detected in SLMT1 and its
hybrids, MCHs 3.11 and 3.22. C. Western blotting analyses do not detect changes of proteins β-catenin, Nanog, and Oct4 in SLMT1 hybrid cells,
compared with their parental SLMT1 cells.
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role of Wnt signaling in the regulation of stemness
networks in human cells, HONE1, SLMT1, and their
hybrid cell lines were used. As expected, strong activa-
tion of endogenous tumor suppressors p53, RB1, and
WT1 was detected in HONE1 hybrid cells, indicating
that genomic integrity controlled by multiple tumor
suppressor pathways within the parental HONE1
cells may be a key factor for maintaining a balanced
environment to keep a low level of β-catenin expres-
sion [18-20].
Consistent with findings of both components of Wnt
pathways and the core stem cell network being
expressed or up-regulated in HONE1 hybrid cells, we
found that the Wnt signal was clearly increased in
HONE1 hybrid cells, as compared with untreated
HONE1 cells. These in vitro observations were further
confirmed in vivo with animal studies, indicating that
there was consistent, up-regulated Wnt/β-catenin sig-
naling in HONE1 hybrid cells.
To exclude the possibility that genes other than
β-catenin on transferred chromosome 3 induced Wnt
signaling in HONE1 hybrid cells, we specifically si-
lenced β-catenin expression using β-catenin shRNA
in these hybrid cells. Following the inhibition of β-catenin, expression of core stem cell genes and EMT
markers was also decreased in the treated hybrid cells.
These observations strongly indicate that β-catenin
signaling, introduced by chromosome 3 transfer, is a
dominant force in the regulation of both stemness and
EMT networks in HONE1 cells, an expression pattern
seen in other tissues [28,30,37-39].
Both chromosome 3 transfer and BIO treatment in
HONE1 cells regulated EMT genes or its regulators.
However, BIO only had similar, not identical biological
effects as the chromosome 3 transfer, as evident in the
control of cadherin switching. The Wnt signal control-
ling these EMT and cadherin networks was evidenced by
the fact that β-catenin protein accumulated at the mem-
branes, as seen in BIO-treated cells, hybrids with trans-
ferred chromosome 3, and recent stemness studies [40].
This may be another regulatory process for entry control
of free β-catenin into the nucleus, but the detailed
mechanism of nuclear localization of β-catenin and the
critical role E-cadherin plays in these processes are still
not fully understood [8,9,21,29,41,42].
The qPCR Array results confirmed that physiological
β-catenin signaling triggered signals through additional
pathways including pluripotency maintenance, FGF, and
TGF-β superfamily signaling in HONE1 hybrid cells. For
Figure 6 The exogenous β-catenin signaling induces an up-regulation of p53 expression in HONE1 hybrid cells and influences
proliferation of treated cells. A. RT-PCR analysis shows that tumor suppressor p53 is up-regulated by Wnt-signaling in HONE1 hybrid cells
compared to parental HONE1 cells. Western blot analysis (right) confirms that p53 expression is also up-regulated in HONE1 hybrid cells (MCH4.4/
4.5/4.6). B. shRNA knockdown of β-catenin is associated with the reduction of tumor cell proliferation. MTT assays indicate cell proliferation rate is
reduced in β-catenin shRNA infected HONE1 hybrid cells in different starting number of cells compared to scramble shRNA control cells. C. The
colony formation assay was performed in matrigel. The colony formation ability in HONE1 hybrid cells with infected β-catenin shRNA is
significantly inhibited on both days 7 and 14 compared to scramble shRNA control cells.
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activated, which confirms previous reports that the TGF-β
signaling pathway is associated with the pluripotency gene
network and the EMT process [30,41]. Many embryonic
development genes such as Activin receptor, ACVR2A,
were activated following the introduction of physiological
β-catenin signaling in treated cells. This suggests that there
are additional signals such as Activin that develop during
culture and may serve to drive the reprogramming or cellself-renewal processes induced by Wnt signaling. It
is also notable that the LIFR- and IL6ST-mediated
pluripotency maintenance pathways, as well as BMP
receptors and Smad families, were activated in HONE1
hybrid cells. Since these signals have well-known links
to self-renewal programs, their increased expression
provides additional evidence that physiological Wnt/β-
catenin signaling is involved in the regulation of the cell
self-renewal networks [4,5,8,17,43].
Figure 7 Analyses of spheres derived from HONE1 hybrid cells. A. RT-PCR analyses show that the expression of genes that encode CSC
markers, CD9, CD24, CD44, CD90, and CD133, in sphere-forming cells (spheres A, B, and C) are progressively up-regulated compared to HONE1
and HONE1 hybrid cells. B. and C. Wnt Signaling Pathway qPCR Array assay lists the 34 up-regulated genes and 12 down-regulated genes in
spheres, compared to HONE1 hybrid MCH4.4.
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physiological Wnt/β-catenin signaling, appears to be a
progressive process leading to a de-differentiated state in
spheres, as demonstrated by analysis of up-regulated
expression of core stem cell genes. Furthermore, genes
that encode surface markers, such as CD9, CD24, CD44,
CD90, and CD133, in spheres were expressed or clearly
up-regulated compared to hybrid cells. Many Wnt
signaling components in sphere-forming cells were
identified as being involved in this stemness transition
process, compared to hybrid cells. More than two-fold
up-regulation of expression was detected in 34 genes,
which included canonical, non-canonical, and Wnt/Ca+2
pathways.
Conclusions
These studies demonstrate that both dosage levels of β-
catenin signaling and genetic background of tissues play
critical roles in the regulation of self-renewal networks
in human cells. There are very limited methods to ex-
plore physiological levels of Wnt/β-catenin signaling in
current biology studies and the results of these studies
indicate that haploid levels of expression of transferred
β-catenin can induce signaling cascades that include
multiple known pathways associated with reprogram-
ming and self-renewal processes. Appropriate Wnt
signaling may drive cancer cells into a progressive de-
differentiated state, which generates expression profiles
for exposure of the regulatory mechanism in stemnesstransition. These novel results clarify the relationships
that are still controversial and rather unclear at present
among Wnt signaling, stemness networks, EMT events,
TSG pathways and expression of common cancer stem
cell surface markers. These findings shed new light on a
variety of cellular processes never before associated with
physiological levels of β-catenin signaling that provide a
framework for future studies to define the molecular
mechanisms governing cell fate determination in human
cells.
Methods
Cell lines and culture conditions
NPC HONE1 cells [44], mouse MCH903.1 cells containing
human chromosome 3, three HONE1 hybrid cell lines
(MCH4.4/4.5/4.6), and four TS cell lines (MCH4.5-1TS/
4.5-2TS/4.6-1TS/4.6-2TS) were cultured as previously
reported [11]. Esophageal carcinoma cell line, SLMT1
and its hybrid cells, MCH3.11/3.22, with transferred
chromosome 3 were cultured as previously reported
[36]. To minimize any possible change of gene expres-
sion influenced by culture conditions, environmental
factors and genetic alterations in cultured cells [7],
RNAs and proteins were obtained from early passages
of hybrid cells and corresponding passages of parental
cells for cell fusion. Human embryonic stem cells, H7,
were obtained from the Stem Cell Core Facility of the
University of Hong Kong and were maintained in
Matrigel-covered plates and mTeSR1 culture medium,
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gies, Vancouver, BC, Canada).
BIO treatment
BIO (Stemgent, San Diego, USA) was stored and diluted
following manufacturer’s instructions. Cells were grown
in T25 flasks to 50% confluence and treated with BIO at
concentrations of 0.5 μM, 1.0 μM, 2.5 μM, 5 μM, 10
μM, and 20 μM. Twenty-four hours later, both BIO-
treated and mock-treated cells were washed in PBS and
harvested for total RNA extraction.
Sphere formation assay
HONE1, HONE1 hybrids, and HONE hybrids with infected
β-catenin shRNA cells were plated in T25 flasks, coated
with 0.1% gelatin at 10–30 viable cells/ml and grown in
Dulbecco’s modified eagle medium (DMEM) supplemented
with 10% FBS. Cells were allowed to grow until spheres
appeared. Three independent experiments were performed.
After spheres formed, non-spheroid cells surrounding the
spheres were scratched off and washed away with PBS daily
in order to maintain the sphere growth. Only 50% of the
culture medium was changed each time. The number of
spheres was recorded under microscopy from 45 to 90 days
after seeding cells. The pooled large and small spheres were
collected for further RNA analysis.
RT2 Profiler PCR array analysis
Stem Cell Transcription Factors, Stem Cell Signaling,
and Wnt Signaling Pathway PCR Arrays were obtain-
ed from SABIOSCIENCES (http://www.sabiosciences.
com/Signal_Transduction.php), a Qiagen Company
(Frederick, MD, USA). Multiple RNA expression (in-
ternal control and housekeeping genes) and genomic
DNA contamination controls are included in these qPCR
arrays. One μg of total RNA was used for the first strand
cDNA synthesis reaction. All reaction procedures and
data analyses were performed following the manufac-
turer’s manual (RT2 Profile PCR Array User Manual
version 5.01) and provided analysis software (RT2 Pro-
filer RCR Array Data Analysis version 3.5).
Infection of shRNAs
Both shRNAs scramble [45] (Addgene plasmid 1864) and
β-catenin [46] (Addgene plasmid 19761), were obtained
from Addgene (Cambridge, MA USA). HEK-293T cells
were incubated at 37°C overnight and transfected with
shRNA plasmid, psPAX2 packaging plasmid, pMD2.G en-
velope plasmid, and FuGENE in DMEM medium, following
Addgene’s protocol. Lentiviral particle solution from
cultured cells was harvested 48 hours later. HONE1 hybrid
cells were plated in T25 flasks overnight and grown to
approximately 80-90% confluence. The following day, 1 ml
infection media was added in 3 ml culture mediumcontaining 8 μg/ml polybrene for 48 hours. The selective
drug puromycin was added 24 hours later. Infected cells
were expanded and the third to fifth passages were col-
lected for subsequent RNA and protein analyses.
Luciferase assay
HONE1 and HONE1 hybrid cells were transiently
transfected using 1 μg of luciferase reporter plasmids
(STOP) and control plasmids (SFOP) with the
Lipofectamine 2000 (Invitrogen) transfection reagent
according to manufacturer’s instructions. Cells were
collected and lysed 48 hours post-transfection. The
luciferase activity was assayed using the Luciferase
Assay System (Promega). The β-galactosidase activity
was assayed using Galacto-Light Plus System (Applied
Biosystems, Life Technologies, Carlsbad, CA, USA).
Both luciferase and β-galactosidase activities were
measured using a TD20/20 luminometer (Turner
Biosystems). STOP/SFOP ratio of luciferase reporter
activities was normalized using β-galactosidase activ-
ities [47,48].
RT-PCR and qPCR analyses
Total RNA was extracted using TRIzol reagent
(Invitrogen, Carlsbad, CA, USA). One microgram of
total RNA was reverse-transcribed with M-MLV Reverse
Transcriptase (USB, Cleveland, OH, USA), as previously
described [48]. All RNAs were treated with DNAse. The
primers and RT-PCR and qPCR conditions are summa-
rized in Additional file 1: Table S2. Human GAPDH was
used as an internal control for all RT-PCR reactions. For
qPCR analysis, triplicate PCR reactions were performed
using the LightCycler 480 Real-Time PCR Instrument
(Roche Diagnositics GmbH, Mannheim, Germany).
Flow cytometry
Antibodies against CD24 and CD44 (BD Pharmingen) were
used for FACS analyses. To sort HONE1 and HONE1
hybrid cells, the collected cells were resuspended in
Pharmingen Stain Buffer and stained with antibodies for 30
min. The antibody-positive cells were sorted by the BD
FACSAria Cell Sorter (San Jose, CA, USA), according to
the protocols provided by the manufacturer.
Cell proliferation assay
The cell proliferation ability was studied using the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium
bromide (MTT) assay. Briefly, 0.5 × 103, 2.0 × 103, and
4.0 × 103 cells were seeded in 96-well plate. The cell prolif-
eration rate was measured consecutively for 5 days. Thirty
μl of 5 mg/ml filtered MTT solution (Sigma Chemical Co.,
St. Louis, MO) was added into the cells and incubated at
37°C for 4 hours. The absorbance at 570 nm was recorded
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Scientific Inc., MA, USA).
Three-dimensional matrigel colony formation assays
A total of 1,000 cells was seeded on the top of Matrigel
(BD Biosciences) and cultured for 14 days in 96-well
plate. Images were captured at 4x and 10x magnification
using Nikon Eclipse Ti inverted microscope (Nikon
Instruments Inc., NY, USA) and analyzed with SPOT
Advanced software (Diagnostic Instruments Inc., MI,
USA). Colonies in 3 fields at 10x magnifications were
counted and reported as the average number of colonies
on the day 7 and 14.
Western blotting and immunofluorescence staining
Cells were seeded onto a 150 mm culture plate and were
then scraped from the plate for Western blotting, which
were performed as previously described [49]. The
primary antibodies for Western blot analyses are sum-
marized in Additional file 1: Table S3. Cells for immuno-
fluorescence staining of β-catenin were grown on glass
coverslips and incubated with primary and secondary
antibodies for overnight and one hour, respectively, and
analyzed by confocal microscopy (LSM 710, Zeiss,
Germany).
Animal assay and immunohistochemical staining
Both HONE1 and HONE1 hybrid cells were injected
into nude mice as previously described [11,12]. Tumors
derived from both HONE1 and HONE1 hybrid cells
were excised for both tissue culture in selective medium
and paraffin-embedded for immunohistochemistry ana-
lysis using antibodies (β-catenin, E-cadherin, and Cyclin
D1) (Additional file 1: Table S3), as described previously
[48]. All animal experiments were approved by the Gov-
ernment of Hong Kong Special Administrative Region
and University of Hong Kong.
Additional file
Additional file 1: Table S1. Expression changes in HONE1 hybrid Cells
(compared to parental HONE1 cells) assayed by Stem Cell Signaling PCR
Array. Table S2. Primers used in RT-PCR and qPCR analyses. Table S3.
Antibodies used.
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